GLP1R and obesity due to melanocortin 4 receptor deficiency: There is a lack of effective pharmacotherapy for NAFLD treatment; however, anti-obesity medications and agents modulating insulin resistance, including GLP-1, are used for the management of NAFLD [136,138].